||WO||WO/2014/126547 - POLYETHYLENE TEREPHTHELATE PART BONDED TO POLYESTER AND POLYCARBONATE ALLOY PART||21.08.2014||
||PCT/US2013/025670||HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.||LEISER, Judson M.|
A device has a first part including polyethylene terephthelate (PET) with a fiber fill and a second part bonded to the first part. The second part includes an alloy of polyester and polycarbonate. The first and second part may be bonded together by placing the first part and the second part in contact with one another and heating the second part to bond the second part to the first part.
||WO||WO/2014/126553 - PAPER FEEDING FOR AN IMAGING SYSTEM||21.08.2014||
||PCT/US2013/025841||HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P.||DOMBROSKI, Ronald Michael|
A system and method for feeding pages in an ADF is disclosed. The system comprises an input tray, a paper picking system and a combined output tray/image platen. The paper picking system is coupled to the input tray and picks pages from a stack of pages loaded into the input tray. The paper picking system feeds the pages in sequence into the combined output tray/image platen. The pages are stacked into the combined output tray/image platen with the first page stacked on the bottom of the stack. An image of the top side of each page can be captured after the page has been stacked into the combined output tray/image platen before the next page is stacked on top.
||WO||WO/2014/126558 - ENCLOSED LASER MEDICAL DEVICE/SYSTEM||21.08.2014||
||PCT/US2013/025915||BIOLITEC PHARMA MARKETING LTD.||NEUBERGER, Wolfgang|
A fiber optic medical device/system is presented, comprising laser source, connectible to optical fibers and enclosed to ensure sterility and safe operation. It is a single use system enclosed and sterilized, including laser source and, optical fiber attached in a sterile tube. Another embodiment is hermetically sealed laser unit with simple connection system to a properly shaped fiber optic. Joined hand piece and fiber can be directly inserted to treat target tissue. Laser handle is aseptically packaged. In other embodiments, fiber is proximally terminated in solid funnel-shaped end to provide unique directional keyed junction with laser unit. In another embodiment, unit includes fiber joined to it, where a laser module can be added away from the fiber end and laser module need not be sterilized, but entire unit is safe for medical use in sterile fields. Enclosure also serves as handpiece for manipulating device. Another preferred embodiment has laser unit attached to a rigid delivery system for laparoscopic procedures.
||WO||WO/2014/126563 - ELEVATOR CAR SPEED CONTROL IN A BATTERY POWERED ELEVATOR SYSTEM||21.08.2014||
||PCT/US2013/026047||OTIS ELEVATOR COMPANY||AGIRMAN, Ismail|
An elevator system includes a battery; a machine having a motor for imparting motion to an elevator car; an inverter for converting DC power from the battery to AC power for the machine in motoring mode and converting AC power from the machine to DC power for the battery in regenerative mode; and a controller to control the inverter, the controller implementing at least one of: detecting an overload at the battery in motoring mode and reducing car speed in response to the overload; detecting an overcharge at the battery in regenerative mode and reducing car speed in response to the overcharge; detecting motor direct current in a motor field weakening mode and reducing car speed in response to the motor direct current; and detecting car load and adjusting car speed in response to car load.
||WO||WO/2014/126587 - BALL CHECK VALVE INTEGRATION TO ICD||21.08.2014||
||PCT/US2013/026533||HALLIBURTON ENERGY SERVICES, INC.||LOPEZ, Jean Marc|
A production sleeve assembly for use downhole comprises a fluid pathway configured to provide fluid communication between an exterior of a wellbore tubular and an interior of the wellbore tubular, a flow restriction disposed in the fluid pathway, and a valve disposed in series with the flow restriction in the fluid pathway. The valve comprises: a rupture disk and a plug releasably engaged in the fluid pathway in series with the rupture disk. The valve is configured to allow production from the exterior of the wellbore tubular to the interior of the wellbore tubular through the chamber without producing past the plug once the rupture disk is actuated.
||WO||WO/2014/126551 - MULTI-STEP ION IMPLANTATION||21.08.2014||
Systems and methods for strengthening a sapphire part are described herein. One embodiment may take the form of a method including orienting a first surface of a sapphire member relative to an ion implantation device and performing a first implantation step. The implanting step may include directing ions at the first surface of the sapphire member to embed them under the first surface. The systems and methods may also include one or more of heating the sapphire member to diffuse the implanted ions into deeper layers of sapphire member, cooling the sapphire member, and performing at least a second implantation step directing ions at the first surface of the sapphire member to embed the ions under the first surface
||WO||WO/2014/126589 - METHOD AND SYSTEM OF PLANNING LATERAL WELLBORES WITHIN IRREGULAR BOUNDARIES||21.08.2014||
||PCT/US2013/026565||LANDMARK GRAPHICS CORPORATION||COLVIN, Richard, D.|
Planning lateral wellbores within irregular boundaries. At least some of the illustrative embodiments are methods including: logically dividing an irregular polygon into a plurality of contiguous sub-areas, the irregular polygon representing an outer boundary of mineral rights; planning a first plurality of layouts of lateral wellbores residing in a first sub-area, each layout along a distinct azimuthal direction; selecting a layout of the first plurality of layouts based on a selection criteria, the selecting creates a first selected layout; planning a second plurality of layouts of lateral wellbores residing in a second sub-area; selecting a layout of the second plurality of layouts based on a selection criteria, the selecting creates a second selected layout; creating an overall layout for the irregular polygon by combining the first and second selected layouts; and displaying the overall layout on a display device.
||WO||WO/2014/126548 - VEHICLE EXHAUST SYSTEM WITH RESONANCE DAMPING||21.08.2014||
||PCT/US2013/025693||FAURECIA EMISSIONS CONTROL TECHNOLOGIES||ABRAM, Kwin|
A vehicle exhaust system includes an exhaust component having an outer surface and an inner surface that defines an internal exhaust component cavity. At least one bleed hole is formed in the exhaust component to reduce a resonance frequency. The bleed hole comprises a discontinuous opening into the exhaust component cavity.
||WO||WO/2014/126574 - METHOD AND APPARATUS FOR APPLICATION AWARENESS IN A NETWORK||21.08.2014||
||PCT/US2013/026225||VMWARE, INC.||FEROZ, Azeem|
A method for enforcing a network policy is described herein. In the method, a network socket event request from an application executing in a first context is intercepted by an agent prior to the request reaching a transport layer in the first context. A context refers to virtualization software, a physical computer, or a combination of virtualization software and physical computer. In response to the interception of the request, the agent requests a decision on whether to allow or deny the network socket event request to be communicated to a security server executing in a second context that is distinct from the first context. The request for a decision includes an identification of the application. The agent then receives from the security server either an allowance or a denial of the network socket event request, the allowance or denial being based at least in part on the identification of the application and a security policy. The agent blocks the network socket event from reaching the transport layer when the denial is received from the security server. In one embodiment, the method is implemented using a machine readable medium embodying software instructions executable by a computer.
||WO||WO/2014/126582 - IL-1β INHIBITOR COMPOSITION AND USE THEREOF||21.08.2014||
||PCT/US2013/026349||R-PHARM, CJSC (CLOSED JOINT STOCK COMPANY)||LAVROVSKY, Yan|
A therapeutic composition is described that can be used for treating or prevention of diseases association with modulation of activity of human IL-1β. In certain aspects, the disclosed invention is based, on engineering of a heterodimeric protein assembly that is capable of binding to human IL-1β and attenuating its function. The heterodimeric protein assembly comprises an extracellular portions of human IL1-R1 and of human IL-1RAcP, or their functional fragments. Each, the IL1-R1 portion and the IL-1RAcP portion, is fused to a distinct mutant of Fc portion of the human Ig Gamma-1. The two distinct Fc mutants in the heterodimeric protein assembly are engineered as to favor the heteromeric dimer formation between the two Fc mutants over any homomeric assembly. DNA expression vectors and expression systems for overproducing the polypeptides in mammalian cells are also provided for.